Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT01689389
Official study titleDescription of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France
This study has finished and is no longer accepting participants.
Multiple locations, including ArgenteuilSchizophrenia, BipolarityObservational studyAges 18–130
- Countries
- France
- Sponsor
- AstraZeneca
CompletedNCT04754750
Official study titleDifferences in Lipid and Cognitive Change Between One-month and 3-month Paliperidone Palmitate Treatment in Stable Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 30–69
- Countries
- Sponsor
- Calo Psychiatric Center
UnknownNCT04892199
Official study titleDoes the Glucagon-like Peptide-1 Receptor Agonist Semaglutide Prevent Deterioration of Metabolic State in Prediabetic or Diabetic Patients With Schizophrenia Treated With the Antipsychotic Compounds Clozapine or Olanzapine?
Current recruitment status is unconfirmed.
Multiple locations, including AarhusSchizophreniaMedication studyAges 18–65
- Countries
- Denmark
- Sponsor
- Anders Fink-Jensen, MD, DMSci
TerminatedNCT00570063
What is this study about?This study evaluates the safety and effectiveness of PF-02545920 for people with schizophrenia.
This study ended early.
Multiple locations, including GlendaleSchizophreniaPlacebo comparisonAges 18–99
- Countries
- United States
- Sponsor
- Pfizer
CompletedNCT00783185
About this title
Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Read the official source — NCT00783185Official study titleDual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis
This study has finished and is no longer accepting participants.
In KonstanzSchizophreniaBehavioural studyAges 18–65
- Countries
- Germany
- Sponsor
- University of Konstanz
CompletedNCT02918630
This study has finished and is no longer accepting participants.
In HoustonSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
CompletedNCT00204061
About this title
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Read the official source — NCT00204061Official study titleEarly Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
This study has finished and is no longer accepting participants.
In CologneSchizophreniaMedication studyAges 14–36
- Countries
- Germany
- Sponsor
- University of Cologne
CompletedNCT03730857
Official study titleEarly Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- Calo Psychiatric Center
TerminatedNCT03852706
Official study titleA Randomized Controlled Pilot Trial of Low-resolution Brain Electromagnetic Tomography (LORETA) Neurofeedback Training for Treatment-resistant Auditory Verbal Hallucinations in Schizophrenia
This study ended early.
In DublinSchizophreniaInterventional studyAges 18+
- Countries
- Ireland
- Sponsor
- University of Dublin, Trinity College
UnknownNCT06505668
Official study titleEffect Of Atenolol Versus Ivabradine On Heart Rate Variability In Treatment Resistant Schizophrenia Patients On Clozapine With Tachycardia: A Randomized Control Trial.
Current recruitment status is unconfirmed.
In BhubaneswarSchizophreniaMedication studyAges 18–60
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
CompletedNCT03868358
This study has finished and is no longer accepting participants.
In HefeiSchizophreniaDevice studyAges 18–52
- Countries
- China
- Sponsor
- WANG KAI